US 7196222
Sertraline hydrochloride form II and methods for the preparation thereof
granted A61PA61P25/24
Quick answer
US patent 7196222 (Sertraline hydrochloride form II and methods for the preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P25/24